MapLight Therapeutics, Inc. earnings releases MPLT

Annual Quarterly

MapLight Therapeutics, Inc. last reported quarterly results on Aug 13, 2026, for Q2 FY2026 (the quarter ended Jun 30, 2026): diluted EPS of -$1.32. It usually reports 9–65 days after a quarter ends. Based on that pattern, the next release is estimated for around Dec 3, 2026.

Release dates are when the company filed its earnings announcement with the SEC (Form 8-K, Item 2.02); select a date to open the filing. It usually reports 9–65 days after a quarter ends. Figures are USD in millions, except EPS. The colored percent is the change from the same quarter a year earlier. Until a quarter's 10-Q or 10-K figures reach the SEC's data, they come from the earnings press release, and are shown only when its year-ago numbers match the filed ones. A dash means the figure could not be confirmed yet.

Released Quarter Revenue Net income Diluted EPS
Aug 13, 2026
44 days after quarter end
Q2 FY2026
ended Jun 30, 2026
—
-60
-1.32
May 14, 2026
44 days after quarter end
Q1 FY2026
ended Mar 31, 2026
—
-61
-1.34
Jan 9, 2026
9 days after quarter end
Q4 FY2025
ended Dec 31, 2025
—
-80
-2.48
Dec 4, 2025
65 days after quarter end
Q3 FY2025
ended Sep 30, 2025
—
-29
-37.18

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
MPLT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Redwood City, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
1770069
Former names
Alvarado Therapeutics, Inc. (until Mar 22, 2019)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.